Nexalin Technology NXL
NASDAQ NXL
$0.33 +0.00 (+0.42%)
At close: Aug 20, 2026 · 2:15 PM UTC

Nexalin Technology (NXL) Property, Plant & Equipment (Net) Growth (3y) (2026)

Nexalin Technology (NXL) Property, Plant & Equipment (Net) Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn 10.68%
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 8.70%
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 10.02%
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 17.65%
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 3.48%
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 13.54%
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 10.10%
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn -2.76%
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 7.96%
10 Nexalin Technology 7.01 Mn 6.00 Mn 8,897.00 466.01%

Historic Data

Download Data
DateValue
Jun 30, 2026 466.01%